<code id='89ED109171'></code><style id='89ED109171'></style>
    • <acronym id='89ED109171'></acronym>
      <center id='89ED109171'><center id='89ED109171'><tfoot id='89ED109171'></tfoot></center><abbr id='89ED109171'><dir id='89ED109171'><tfoot id='89ED109171'></tfoot><noframes id='89ED109171'>

    • <optgroup id='89ED109171'><strike id='89ED109171'><sup id='89ED109171'></sup></strike><code id='89ED109171'></code></optgroup>
        1. <b id='89ED109171'><label id='89ED109171'><select id='89ED109171'><dt id='89ED109171'><span id='89ED109171'></span></dt></select></label></b><u id='89ED109171'></u>
          <i id='89ED109171'><strike id='89ED109171'><tt id='89ED109171'><pre id='89ED109171'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:entertainment    Page View:4237
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In